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EmerinEven though the Duchenne muscular dystrophy (DMD) gene product Dystrophin Dp71d is involved in various
key cellular processes through its role as a scaffold for structural and signalling proteins at the plasmamembrane
as well as the nuclear envelope, its subcellular trafﬁcking is poorly understood. Here we map the nuclear import
and export signals of Dp71d by truncation and point mutant analysis, showing for the ﬁrst time that Dp71d shut-
tles between the nucleus and cytoplasmmediated by the conventional nuclear transporters, importin (IMP)α/β
and the exportin CRM1. Binding was conﬁrmed in cells using pull-downs, while in vitro binding assays showed
direct, high afﬁnity (apparent dissociation coefﬁcient of c. 0.25 nM) binding of Dp71d to IMPα/β. Interestingly,
treatment of cells with the microtubule depolymerizing reagent nocodazole or the dynein inhibitor EHNA both
decreased Dp71d nuclear localization, implying that Dp71d nuclear import may be facilitated by microtubules
and the motor protein dynein. The role of Dp71d in the nucleus appears to relate in part to interaction with
the nuclear envelope protein emerin, and maintenance of the integrity of the nuclear architecture. The clear im-
plication is that Dp71d's previously unrecognised nuclear transport properties likely contribute to various, im-
portant physiological roles.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Duchenne muscular dystrophy (DMD) is a progressive and lethal
X-linked inherited neuromuscular disorder that results, in the major-
ity of cases, from large out-of-frame deletions or duplication in the
DMD gene leading to absence or dysfunction of the dystrophin protein
[1,2]. The DMD gene exhibits complex transcriptional regulation; it
drives the synthesis of a variety of dystrophin isoforms through alter-
native internal promoters. Full-length dystrophin (427 kDa) is derivedt grant number: 128418 to BC.
ralia); Contract grant number:
. San Pedro Zacatenco, Deleg.
52 55 5061 3339; fax: +52 55
mistry and Molecular Biology,
tralia. Tel.: +61 3 9902 9341;
bcisnero@cinvestav.mx
ights reserved.from three independent promoters at the 5′-end of the DMD gene
[3,5], while the N-terminally truncated dystrophin variants Dp260,
Dp140, Dp116, and Dp71 are produced from alternative internal pro-
moters [6,9].
The shortest DMD gene product, Dp71, is also expressed in a wide
variety of non-muscle tissues [7,10,11]; however, its levels vary greatly
between different tissue and cell types, aswell as during differentiation,
via tight regulation of Dp71 promoter activity [12,13]. In similar fashion
to full-length dystrophin in skeletal muscle, Dp71 associates with dys-
trophin associated proteins (DAPs) such as dystroglycans, sarcoglycans,
dystrobrevins, syntrophins, and accessory proteins to form the
Dystrophin-associated protein complex (DAPC) in non-muscle tissues.
DAPC serves as a bridge to connect the extracellular matrix to the cyto-
skeleton, providing structural stability to the plasma membrane, and
modulating cell signalling events across it [1]. Since Dp71 is the most
abundant DMD gene product in adult brain [1,7,14] and because DMD
patients with mutations located in the Dp71 genomic region display
severe mental retardation ([15,16], reviewed in [17]), loss-of-function
of Dp71 has emerged as amajor contributing factor to cognitive impair-
ment inDMDpatients. Furthermore, the involvement of Dp71 in various
different cellular processes, including ion and water homeostasis
[18,19], cell adhesion [20,22], cell cycle division [23] and maintenance
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well as murine models.
In spite of being initially described as a cytoplasmic/plasma
membrane-associated protein, Dp71 has been found in the nucleus of
a number of different cell types, including hippocampal neurons, fore-
brain astrocytes, as well as in cell lines such as PC12, HeLa, and C2C12
[24,27]. Interestingly, alternative splicing of exon 78 of Dp71 results in
several different isoforms of the protein that show differential subcellu-
lar localisation. Dp71d, for example, includes the domains encoded by
exons 78 and 79 and exhibits a predominant nuclear localisation,
while Dp71f, a variant harboring an alternative 31 amino acid C-
terminal domain, through removal of exon 78, is exclusively cytoplas-
mic [28,30]. Themolecularmechanismsmodulating thenuclear translo-
cation of Dp71d, however, remain to be deﬁned.
Nuclear import and export of proteins N~40 kDa is highly regulated
in eukaryotic cells. Nuclear import is conventionally dependent on the
recognition of nuclear localisation signals (NLSs) by members of the
importin (IMP) superfamily of proteins, of which there are multiple α
andβ forms. Nuclear export is an analagous process that requires nucle-
ar export signals (NESs), which are recognised by exportins, a subset of
IMPβ homologues [31,32]. In the present study, we characterize the
nuclear transport pathway of Dp71d for the ﬁrst time.We identify func-
tional NLS and NES motifs that are responsible for nucleocytoplasmic
shuttling of Dp71d and demonstrate that Dp71d's nuclear import is
mediated by IMPα/β1, while its nuclear export is dependent on
exportin-1/CRM1. Intriguingly, Dp71d nuclear import also appears to
be facilitated by microtubules and the motor protein dynein. We also
show for the ﬁrst time that the role of Dp71d in the nucleus appears
to relate to interaction with the nuclear envelope protein emerin, and
maintenance of the integrity of the nuclear architecture. The results
shed important light on how Dp71d can enter/exit the nucleus, to fulﬁl
its various diverse roles in the cell.Table 1
Oligonucleotides used in this study. Mutant codons are denoted by bold letters.
Assay Vector/mutant
Cloning pGEX4T1-Dp71
pEGFPN1-Dp71
pTetraGFP-Dp71
pTetraGFP-Amino
pTetraGFP-Carboxyl
pTetraGFP-ZZCarboxyl
pTetraGFP-AminoΔZZ
pTetraGFP-ZZ
pGEX4T1-ZZ
pSG5-Emerin
Cloning by BP recombination pDEST17-ZZ
Mutagenesis ZZ-1
ZZ-2
ZZ-3
ZZ-4
ZZ-5
NES mut2. Materials and methods
2.1. Plasmid constructs
Encoding sequence of mouse Dp71d was ampliﬁed by PCR using
pRcCMV2-Dp71d [33] as the template, and the oligonucleotides
described in Table 1. The PCR fragment was then inserted in frame
into EcoRI-digested plasmids pGEX-4 T1 (Amersham Bioscience, GE
Healthcare, Buckinghamshire, UK) for expression of GST-Dp71d fu-
sion protein in bacteria, or pEGFP–N1 vector (Clontech Laboratories,
Inc.) for expression of GFP-Dp71d protein fusion in eukaryotic cells.
For analysis in transfected mammalian cells of full-length Dp71d and
its truncation derivatives fused to TetraGFP, the respective cDNA frag-
ments (full-length, Amino, Carboxyl, AminoΔZZ and ZZ) were ampli-
ﬁed by PCR from the pRcCMV-Dp71d vector using the appropriate
oligonucleotides (see Table 1). PCR fragments ﬂanked by EcoRI sites
were digested and cloned in frame into plasmid pTetraGFP [34],
which encodes for four GFP in tandem, and has a multiple cloning
site between the third and the fourth GFP. pSG5-Emerin vector was
generated for in vitro binding assays of Dp71dwith emerin. The coding
sequence of human emerin was ampliﬁed by PCR fromHeLa cell cDNA
using the oligonucleotide primers described in Table 1, and the PCR
fragment then digested and inserted in frame into BamH1-digested
plasmid pSG5 vector.
Mutant variants of the ZZ domain of Dp71d, containing single [ZZ-1
(H241A), ZZ-2 (C251A), ZZ-3 (H263A), ZZ-4 (C272A)] or combined [ZZ-
5 (C251A and H263A)] mutations in the zinc-chelating amino acid res-
idues, and the Dp71dNES derivativemutant (NESmut) were generated
by site-directed mutagenesis using the pTetraGFP-ZZ and pGFP-Dp71d
vectors as templates respectively, and the oligonucleotides listed in
Table 1. Brieﬂy, 50 ng of the plasmid (pTetraGFP-ZZ or pGFP-Dp71d)
were used in a PCR reaction containing 0.5 μl of Herculase II FusionOligonucleotide sequence
Forward 5′-A GTC GAA TTC ATG AGG GAA CAG CTC AAA GG-3′
Reverse 5′-A GTC GAA TTC CTA CAT TGT GTC CTC TCT CAT-3′
Forward 5′-A GTC GAA TTC ATG AGG GAA CAG CTC AAA GG-3′
Reverse 5′-A GTC GAA TTC TCA TTG TGT CCT CTC TCA T-3′
Forward 5′-AG TCG AAT TCT ATG AGG GAA CAG CTC AAA GG-3′
Reverse 5′-AGT CGA ATT CTT CAT TGT GTC CTC TCT CAT-3′
Forward 5′-AG TCG AAT TCT ATG AGG GAA CAG CTC AAA GG-3′
Reverse 5′-AGT CGA ATT CCC CGT TTC CAT GTT GTC CCC CTC-3′
Forward 5′-AG TCG AAT TCT TGT GGA ATA TTG CAC TCC GA-3′
Reverse 5′-AGT CGA ATT CTT CAT TGT GTC CTC TCT CAT-3′
Forward 5′-AG TCG AAT TCA GAG TGG CTG CTG CAG AAA CT-3′
Reverse 5′-AGT CGA ATT CTT CAT TGT GTC CTC TCT CAT-3′
Forward 5′-AG TCG AAT TCT ATG AGG GAA CAG CTC AAA GG-3′
Reverse 5′-AGT CGA ATT CCT TCT GTG CAG GAC GGG CAG CCA-3′
Forward 5′-AG TCG AAT TCT AGA GTG GCT GCT GCA GAA ACT-3′
Reverse 5′-AGT CGA ATT CCC CGT TTC CAT GTT GTC CCC CTC-3′
Forward 5′-AG TCG AAT TCA GAG TGG CTG CTG CAG AAA CT-3′
Reverse 5′-AGT CGA ATT CCC CGT TTC CAT GTT GTC CCC CTC-3′
Forward 5′-ACTGGATCCATGGACAACTACGCAGATCT-3′
Reverse 5′-ACTGGATCCCTAGAAGGGGTTGCCTTCT-3′
Forward 5′-GGGGACAAGTTTGTACAAAAAAGCAGGCGTGGCTGCTGCAGAAACTGC-3′
Reverse 5′-GGGGACCACTTTGTACAAGAAAGCTGGGTTCACGTTTCCATGTTGTCCCCCTC-3′
Forward 5′-GAA ACT GCC AAG GCT CAG GCC AAA TG-3′
Reverse 5′-CA TTT GGC CTG AGC CTT GGC AGT TTC-3′
Forward 5′-C ATC TGC AAA GAG GCT CCA ATC ATT G-3′
Reverse 5′-C AAT GAT TGG AGC CTC TTT GCA GAT G-3′
Forward 5′-C AGG AGT CTA AAG GCC TTT AAT TAT G-3′
Reverse 5′-C ATA ATT AAA GGC CTT TAG ACT CCT G-3′
Forward 5′-AC ATC TGC CAA AGC GCC TTT TTT TCT G-3′
Reverse 5′-C AGA AAA AAA GGC GCT TTG GCA GAT GT-3′
ZZ-2 and ZZ-3 combined
Forward 5′-G GAG TCA CAG GCA CAC AGG GCA AGG CAG GCG CTG GAG CAA CC-3′
Reverse 5′-GG TTG CTC CAG CGC CTG CCT TGC CCT GTG TGC CTG TGA CTC C-3′
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Herculase II reaction buffer, 0.2 mMdNTPs, 10 pmol of each oligonucle-
otide andwater to 50 μl. Following temperature cycling, DpnI treatment
was performed to cleave parental DNA and to improve the efﬁciency of
the mutant plasmid screening. The reaction was transferred into Top10
competent cells, and the transformationmixturewas plated on LB kana-
mycin plates. Plasmid integrity was conﬁrmed in all cases by DNA
sequencing.
The plasmid construct for bacterial expression of the ZZ domain of
Dp71d fused to His6-tag was generated using the Gateway™ system
(Invitrogen, Carlsbab, CA, USA). The DNA fragment encoding the ZZ
domain was ampliﬁed by PCR using primers containing attB1 and
attB2 recombination sites (Table 1). The PCR fragment was recombined
into the pDONOR207 vector via the BP recombination reaction and the
resulting plasmid, pDONOR207-ZZ, was then used to perform an LR re-
combination reaction with the prokaryotic expression vector pDEST17
to generate pDEST17-ZZ plasmid. The integrity of the constructwas ver-
iﬁed by DNA sequencing. Expression vectors encoding His6-tagged GFP
alone aswell as GST (glutathione S-transferase) alone or fused tomouse
IMPα2 and β1 have been previously described [35,36]. The plasmid
encoding DsRed-RanQ69L (DsRed-dominant negative mutant of Ran)
was provided by Michael Green [37].
2.2. Antibodies
The following primary antibodies were used: +78Dp71 (Genemed
Synthesis Inc. San Francisco, CA, USA) [25] andWB78 (Washington Bio-
technology, Inc., Baltimore, USA), rabbit polyclonal antibodies directed
against the C-terminal 13 amino acids of dystrophin. Rabbit polyclonal
antibodies directed against IMPα2 (B-9), IMPβ2 (A-11), α-tubulin (B-
7), emerin (FL-254) (Santa Cruz Biotechnology, Santa Cruz, CA., USA);
IMPβ1 (3E9) (Abcam, Cambridge, UK); and a mouse monoclonal anti-
body that recognizes the central domain of actin [38], kindly provided
by Dr. Manuel Hernández from CINVESTAV-IPN.
2.3. Tissue culture and transfection
Cells from the C2C12, HTC and PC12 cell lines, as well as the PC12
derivative clone AS1-Dp71, were grown as previously [25,27,39].
Where indicated, cells were subjected to various treatments. These
included incubation for 24 h with the zinc chelator agent N,N,N′,N′-
Tetrakis-(2-pyridylmethyl)-ethylenediamine (TPEN; Sigma-Aldrich, St
Louis, Missouri, USA) at 1.1 μM, or for 4 h with 20 μg/ml cytochalasin
B (Sigma-Aldrich, St Louis, Missouri, USA) or for 5 h with 5 μg/ml
nocodazole (Sigma-Aldrich, St Louis, Missouri, USA) to disrupt the
cytoskeleton. For inhibition of nuclear protein import or export, cells
were treated with 20 μg/ml Agaricus Bisporus lectin (ABL, from edible
mushroom; Sigma-Aldrich, St Louis, Missouri, USA) for 24 h or
100 ng/ml Leptomycin B (LMB; Sigma-Aldrich, St Louis, Missouri,
USA) for 24 or 12 h. Kinesin and dynein were inhibited by incubation
for 12 h with 10 μM aurintricarboxylic acid (AA; Sigma-Aldrich, St
Louis, Missouri, USA) or with 1 mM erythro-9-(2-hydroxy-3-nonyl)
adenine (EHNA; Sigma-Aldrich, St Louis, Missouri, USA), respectively.
Cells were transfected using lipofectamine 2000 (Invitrogen, Carlsbad,
California, USA), following the provider's protocol, and analysed 24 h
post-transfection. Where the role of Ran was tested, cells were trans-
fected to express dsRed-RanQ69L, a dominant-negative Ran mutant
that is locked in the GTP-bound conformation and thus inhibits IMP-
dependent nuclear protein import [37].
2.4. Immunoﬂuorescence and confocal laser scanning microscopy
Cells plated on coverslips were ﬁxed and permeabilized following
standard procedures, and incubated overnight at 4 °C with the anti-
Dp71 antibody WB78 (Washington Biotechnology, Inc., Baltimore,
USA). Cells were then washed with PBS and incubated for 1 h at roomtemperature with a ﬂuorescein-conjugated goat anti-rabbit IgG
(Zymed Laboratories, Inc. San Francisco, CA, USA). To stain nuclei, cells
were incubated for 10 min at room temperature with 500 μg/ml
propidium iodide (PI, Sigma-Aldrich, St Louis, Missouri, USA) or
0.2 μg/μl DAPI (Sigma-Aldrich, St Louis, Missouri, USA). Cell prepara-
tions were mounted on microscope slides with VectaShield (Vector
Laboratories Inc. Burlingame, CA, USA) and visualized on a confocal
laser scanning microscope (TCP-SP5, Leica Microsystems, Heidelberg,
Germany) using a Plan Neo Fluor 63× (NA= 1.4) oil-immersion objec-
tive. Image analysis of digitized confocal microscopic ﬁles using the
ImageJ 1.62 software to determine the nuclear to cytoplasmic ratio
(Fn/c) were performed as previously [40,41].2.5. Immunoprecipitation
Nuclear extracts (500 μg) were pre-cleared with recombinant pro-
tein G-agarose beads (Invitrogen, Carlsbab, CA, USA) for 2 h at 4 ºC;
next, beads were removed by centrifugation at 1250 g for 5 min and
pre-cleared extracts were incubated overnight at 4 ºC with the appro-
priate immunoprecipitating antibody. Parallel incubationswith an irrel-
evant IgG0 antibody were performed. Thereafter, 10 μl of protein G-
agarose beadswere added and incubated overnight at 4 ºC. The immune
complexes were collected by centrifugation at 1250 g for 5min, washed
three times for 5 min with 500 μl of wash buffer [50 mM Tris–HCl
pH 8.0, 150 mM NaCl, 1 mM EDTA pH 8.0, 0.5% (v/v) Triton X-100,
0.05% (w/v) SDS and 1 mM PMSF], and eluted by boiling in 10 μl of
Laemmli sample buffer [50 mM Tris–HCl pH 6.8, 2% (w/v) SDS, 10%
(v/v) glycerol, 1% (v/v) 2-mercaptoethanol, 0.01% (w/v) bromophenol
blue]. GFP fusion proteins were immunoprecipitated using the GFP-
Trap® bead system (Chromotek, Germany) in accordance with the
manufacturer's instructions.2.6. Cell fractionation and Western blotting
Isolation of total, cytosolic and nuclear extracts were carried out as
described [25]. Protein samples (80 μg) were electrophoresed on 10%
SDS-polyacrylamide gels and transferred to nitrocellulose membranes
(Hybond-N+, Amersham Pharmacia, GE Healthcare, Buckinghamshire,
UK) by using a Transblot apparatus (Bio-Rad, Hercules, CA, USA). Mem-
branes were blocked for 1–3 h in TBS-T [10 mM Tris-HCl pH 8.0,
150 mM NaCl, 0.05% (v/v) Tween-20] with 6–15% (w/v) low-fat dried
milk. Next, membranes were incubated overnight at 4 °C with the ap-
propriate primary antibody. After three washes in TBS-T, membranes
were incubated with the corresponding horseradish peroxidase-
conjugate secondary antibody (Amersham Pharmacia, GE Healthcare,
Buckinghamshire, UK) and developed using the ECL Western blotting
analysis system (Amersham Pharmacia, GE Healthcare, Buckingham-
shire, UK).2.7. Bacterial protein expression and puriﬁcation
The ZZ domain of Dp71d was puriﬁed from bacteria as His6-tagged
protein using nickel afﬁnity chromatography under native condi-
tions [42]. The IMP proteins were expressed and puriﬁed from bacteria
as GST-fusion proteins under native conditions as described [35]. Pro-
teins were then further puriﬁed by gel ﬁltration using a HiPrep 26/60
Sephacryl S-200 High Resolution column attached to an ÄKTA Puriﬁer
system (GE Healthcare Company, Buckinghamshire, UK) and concen-
trated using Amicon centrifugal concentrators (Millipore Corporation,
Billerica, MA, USA). Expression of GST and GST-Dp71d proteins was
induced as described [22]. Protein concentrations were estimated by
absorbance measurement at 280 nm and the theoretical molar extinc-
tion coefﬁcient.
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IMPα/IMPβ1were biotinylated using the sulfo-NHS-biotin (sulfo-N-
hydroxysuccinimide Biotin) reagent. Brieﬂy, 3.5mg of IMPwas incubat-
edwith 250 μl of 10mMsulfo-NHS-Biotin on ice for 2 h. Unbound biotin
was removed using a PD-10 desalting column (GEHealthcare Company,
Buckinghamshire, UK), and the resultant biotinylated IMPs were con-
centrated to between 100 and 250 μM in an Amicon-30 centrifugal
concentrator.
Interaction betweenHis6-tagged ZZ fusion protein and biotinylated-
IMPs was assessed using an established ALPHAScreen assay
(PerkinElmer, Wellesley, MA, USA) [43], whereby IMPs α2 and β1
were pre-dimerized at 13.6 μM for 15min at room temperature in intra-
cellular buffer (20mMHEPES pH7.4, 110mMKCl, 5mMNaHCO3, 5mM
MgCl2, 1mMEGTA, 0.1mMCaCl2, 1mMDTT) to generate the IMPα2/β1
heterodimer for binding studies. 384-well white Optiwell plates
(PerkinElmer, Wellesley, MA, USA) were coated with 30 nM of His6-
tagged ZZ fusion protein/well and incubated for 30 min with increasing
IMP concentrations (0–60 nM). 1 μl of a 1:10 dilution of the nickel che-
late acceptor beads and 1 μl of 2.5% (w/v) of BSA was subsequently
added and the samples incubated at room temperature for 90 min.
1 μl of a 1:10 dilution of the streptavidin donor beads was then added
and the samples were incubated at room temperature for a further
2 h. Protein binding was subsequently detected using a FusionAlpha
plate reader (Perkin Elmer, Wellesley, MA, USA).2.9. GST binding assays
5 μg of GST and GST–Dp71d proteins bound to glutathione-
Sepharose beads was incubated overnight with 1 mg of total protein
extract of C2C12 cells at 4 °C in interaction buffer [50 mM Tris–HCl
pH 8′0, 150 mM NaCl, 1 mM PMSF, 1% (v/v) Triton X-100, 0.05% (w/v)
SDS, 1× complete protease inhibitor cocktail (Roche Applied Science,
Indianapolis, USA)]. Beads were recovered by centrifugation at 1000 g
at 4 °C and washed three times in 1 ml of ice-cold Wash Buffer
[50 mM Tris–HCl pH 7.5, 150 mM NaCl, 1 mM EDTA pH 8.0, 1 mM
PMSF, 1% (v/v) Triton X-100]. Finally, proteins were eluted by adding
1 volume of 2× Laemmli buffer and heating at 95 °C, 5 min. Interacting
proteins were identiﬁed by SDS-PAGE and Western analysis using the
appropriate primary antibodies. For in vitro binding of Dp71d with
emerin, full-length emerin was produced by in vitro transcription-
translation of pSG5-Emerin plasmid using the TnT® Quick Coupled
Transcription/Translation System in the presence of [35S]methionine
(Amersham Bioscience, GE Healthcare, Buckinghamshire, UK), ac-
cording to the manufacturer's instructions (Promega, Madison, WI,
USA). Afﬁnity puriﬁed GST and GST–Dp71d proteins immobilised on
glutathione-Sepharose beads (2.5 μg) were incubated with 35S-Emerin
overnight at 4 °C with agitation in binding buffer (140 mM K-acetate,
15mMHepes, pH 7.1, 1.5 mMEDTA, 5 mMMgSO4). After overnight in-
cubation, glutathione beads were washed extensively three times with
binding buffer containing 0.5% (v/v) Triton X-100, eluted with Laemmli
sample buffer and subjected to SDS-PAGE. Gels were imaged using the
Typhoon trio (Amersham Bioscience, GE Healthcare, Buckinghamshire,
UK).2.10. DTAF labelling of His6-ZZ
His6-ZZ proteinwas expressed in bacteria, puriﬁed byNickel-afﬁnity
chromatography, and ﬂuorescently labelled with DTAF (5,-[4,6-
dichlorotriazinyl]aminoﬂuorescein). 500 μg His6-ZZ was incubated
with 0.4 mg/ml DTAF dissolved in 250 mM Bicine buffer (N,N-bis(2-
hydroxyethyl)-glycine), pH9.5, room temperature for 90min. Unbound
excess dye was removed using a PD-10 desalting buffer (Amersham
Bioscience, GE Healthcare, Buckinghamshire, UK).2.11. In vitro reconstitution of nuclear transport
Nuclear transport of ﬂuorescently labelled His6-ZZ (DTAF-ZZ) was
reconstituted in vitro inmechanically perforated HTC cells as previously
[44], with GFP-tagged SV40 large tumour antigen (GFP-T-ag) used as a
control. Brieﬂy, the plasma membrane was perforated mechanically,
leaving the nuclear envelope intact. Perforated cells were then inverted
on to a microscope slide, into 5 μl of nuclear transport mix, consisting of
45 mg/ml rabbit reticulocyte lysate (Promega, Madison, WI, USA), an
ATP regenerating system (0.125 mg/ml creatine kinase, 30mMcreatine
phosphate and 2 mM ATP), 70 kDa Texas Red-conjugated dextran (to
monitor nuclear integrity), and 2 μM DTAF-ZZ or GFP-T-ag in IB buffer
(intracellular buffer; 110 mM KCl, 5 mM NaHCO3, 5 mM MgCl2, 1 mM
EGTA, 0.1 mM CaCl2, 20 mM HEPES and 1 mM dithiothreitol, pH 7.4).
The involvement of individual IMPs in Dp71d nuclear importwas deter-
mined by preincubating reticulocyte lysate for 15 min at room temper-
ature with inhibitory monoclonal antibodies to IMPα2 (Rch1), β1 or β3
(BD Biosciences, San Jose, CA, USA). To determine the extent to which
binding to nuclear components contributes to nuclear accumula-
tion, 0.025% CHAPS (3-[(3-cholamidopropyl) dimethylammonio]-1-
propanesulfonic acid) was included to permeabilise the nuclear enve-
lope (see [45,47]); only proteins able to bind to nuclear components
are able to accumulate in the nucleus under these conditions.
3. Results
3.1. The ZZ domain is required for Dp71d nuclear import
Although nuclear localisation of Dp71d implies the existence of a fa-
cilitated nuclear import mechanism, the NLS responsible has not been
identiﬁed. As a ﬁrst step to address this, we subcloned full-length
Dp71d or its N- and C-terminal halves into the Tetra-GFP reporter sys-
tem (Fig. 1A), which encodes four in-frame fused copies of GFP [34],
to generate GFP-tagged truncation derivatives of Dp71d larger than 45
kDa, the upper limit for free diffusion through the NPC. Analysis in
transfected cells expressing the constructs by confocal ﬂuorescence mi-
croscopy (CLSM) revealed that both full-length and the N-terminal por-
tion ofDp71d (TetraGFP-Amino), containing theWWdomain, EF-hands
motifs and the ZZ domain, readily targeted TetraGFP to the nucleus,
while the C-terminal half of Dp71d (TetraGFP-Carboxy), bearing the
syntrophin-binding domain and leucine heptads motifs, was retained
in the cytoplasm (Fig. 1B). Quantitative analysis of confocal images to
determine the nuclear to cytoplasmic ratio (Fn/c) conﬁrmed these ob-
servations, with TetraGFP-Dp71d and TetraGFP-Amino exhibiting Fn/c
values of c. 0.7, signiﬁcantly higher than that of TetraGFP alone (Fn/c
of 0.44 (Fig. 1C)). It has previously been shown that the NLS of several
zinc ﬁnger-containing proteins are localised to their zinc ﬁnger regions
[48,52], and hence we generated two additional GFP-tagged constructs
(Fig. 1A). Removal of the ZZ domain from the N-terminal construct re-
sulted in reduced nuclear localisation of TetraGFP, suggesting that this
domain is responsible for Dp71d nuclear localisation. Similarly, the ZZ
domain alone appeared to be sufﬁcient to target Tetra-GFP to the nucle-
us (Fig. 1B), Fn/c value of 2.0 (Fig. 1C), supporting the idea that the ZZ
domain confers Dp71d nuclear localisation.
To determine the requirement for Zn2+-binding on the nuclear
translocation of Dp71d conferred by the ZZ domain, the effect of the
zinc-chelating agent TPEN on endogenous Dp71d nuclear localisation
was analysed. Strikingly, TPEN-treated cells exhibited a drastic
reduction in nuclear staining for endogenous Dp71d, compared
with control cells (Fig. 2A; Fn/c value of 0.5 compared to that of
1.6 in its absence — Fig. 2A right); similarly, the predominantly nu-
clear localisation of TetraGFP-ZZ was reduced by TPEN treatment
(Fig. 2B; Fn/c value of 1.8 compared to c. 3 in its absence — Fig. 2B
right). This was also conﬁrmed using subcellular fractionation ap-
proaches, with analysis of total, cytosolic and nuclear extracts
from C2C12 cells revealing that although the total levels of Dp71d
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cant decrease (p = 0.0084) in the level of Dp71d in the nucleus
upon TPEN treatment (Fig. 2C, left; n/c ratio of c. 1 in the presence
of TPEN compared to 1.6 in its absence, Fig. 2C right). TPEN had no
effect on the subcellular distribution of β-dystroglycan, a protein
that lacks a zinc ﬁnger but localises in the nucleus in NLS/IMP-dependent fashion [40], as indicated by immunoﬂuorescence/
CLSM (Supp. Fig. 1A) as well as subcellular fractionation/Western
analysis (Supp. Fig. 1B), conﬁrming the speciﬁcity of the effect of
TPEN on Dp71d, as a zinc ﬁnger-containing protein.
The effect of single alanine substitutions of key residues within the
dual Zn2+-ﬁngers of Dp71d (see also [53]), or combinations thereof
was tested for the effect on subcellular localization (the schematic in
Fig. 3 indicates the site of themutations). Substitution of single histidine
residues in the ﬁrst (ZZ-1) and second (ZZ-3) Zn2+-ﬁngers, as well as
substitution of the third cysteine in the ﬁrst Zn2+-ﬁnger (ZZ-2) did
not reduce the prominent nuclear localisation of the TetraGFP-ZZ fusion
protein (Fn/c values of 2 or above in all cases, including wild type; Fig. 3
bottom). The ZZ-3 substitution, in fact, increased the extent of nuclear
accumulation (Fn/c of c. 5), presumably as a result of an unmasking
effect (see [54]) with respect to other residues within the Zn2+-ﬁnger
region of Dp71d that may contribute to Dp71d nuclear localization. In
contrast, substitution of the second cysteine in the second Zn2+-ﬁnger
(ZZ-4), markedly reduced nuclear localisation of TetraGFP-ZZ (Fn/c of
0.6; Fig. 3 bottom), consistent with the idea that speciﬁc amino acid
residues within the Zn2+-ﬁngers play a critical role in Dp71d nuclear
import. A combination of the ZZ-2 and enhancing ZZ-3 substitutions
(ZZ-5) also resulted in reduced nuclear accumulation (Fn/c of 1.3), indi-
cating that the Dp71d NLS is complex, and dependent not only on the
Zn2+-ﬁngers themselves, but potentially also on other residues within
the Zn2+-ﬁnger domain (see above; [48,50,55]).
3.2. Nuclear import of Dp71d is dependent on nuclear pore proteins
and Ran
To assess whether ZZ-mediated nuclear translocation of Dp71d is
dependent on a conventional IMP-dependent pathway, we ﬁrst exam-
ined whether the effect of A. bisporus lectin (ABL), which targets the
N-acetyl glucosamine sugar moiety within many of the nucleoporins
that make up the NPC, hence perturbing NPC-dependent nuclear trans-
port [56], can alter the subcellular distribution of Dp71d. We found
that ABL could indeed inhibit nuclear accumulation of endogenous
Dp71d in C2C12 cells (Fig. 4A), resulting in a predominantly cytoplas-
mic localisation in contrast to the nuclear localisation observed in its ab-
sence (Fn/c values of 0.7 compared to 1.3 respectively; Fig. 4A below).
Similarly, nuclear accumulation of the TetraGFP-ZZ domain was re-
duced in ABL-treated cells (Fig. 4B), resulting in a Fn/c of 0.9 compared
to that of 2.8 in its absence (Fig. 4B bottom). Similar results to those for
Dp71d and TetraGFP-ZZ were observed for IMP-dependent nuclear
accumulation of β-dystroglycan (see above [41]), but no effect was ob-
served for GFP, a protein that passively enters the nucleus (Supp.
Fig. S2AB), underlining the speciﬁcity of the effects. The results are
thus consistent with the idea that Dp71d accesses the nucleus via the
NPC, dependent on nucleoporin function.
Conventional IMP-dependent nuclear import through the NPC is
dependent on the guanine nucleotide binding protein/GTPase Ran,
which affects disassembly of IMP-cargo complexes [57,58]; to test the
dependence of Dp71d nuclear accumulation on Ran, a RanQ69L
dominant-negative mutant was used that is locked in the GTP-bound
conformation and thus able to inhibit IMP-dependent nuclear proteinFig. 1. The ZZ domain is necessary and sufﬁcient for Dp71d nuclear localisation. (A) Sche-
matic representation ofDp71d and its truncated derivatives fused to the TetraGFP reporter
protein. The numbers on the left indicate the corresponding amino acid residues of Dp71d
encoded by the fragments in each reporter construct. (B) C2C12 cells cultured on glass
coverslips were transiently transfected with the indicated constructs, ﬁxed 24 h post-
transfection and stained with propidium iodide (PI) to enable visualization of nuclei.
Cells were imaged by CLSM, with typical single Z-sections shown (scale bar is 10 μm).
(C) Quantitative analysis for the nuclear to cytoplasmic ratio (Fn/c) of the reporter
proteins was performed using the ImageJ software, as described in Section 2. Results
represent themean+/− SEM (n N 50) from a series of three separate experiments. Signif-
icant differences between TetraGFP and full-length Dp71d and its truncated derivatives
are denoted by the p values (Student's t-test).
Fig. 2. The Zn2+-chelating agent TPEN reduces nuclear localisation of Dp71d. (A) C2C12 cells seeded on glass coverslipswere incubated for 24 hwith 1.1 μMTPEN inDMSOorDMSOalone
(control), prior to ﬁxation, immunolabelling with anti-Dp71 antibody (green) and counterstaining with DAPI to enable nuclei to be visualized (blue). (B) C2C12 cells cultured on glass
coverslips were transiently transfected with TetraGFP-ZZ construct and treated with TPEN 8 h later as described above, prior to ﬁxation and staining with DAPI. Scale bar 10 μm. In
both cases, confocal images such as those shown were subjected to image analysis as described in the legend to Fig. 1 for endogenous Dp71d (A) or TetraGFP-ZZ (B). Results represent
themean+/− SEM(n N 50) froma series of three separate experiments,with signiﬁcant differences between control and TPEN-treated cells denotedby the p values. C) Cellswere treated
without or with TPEN as above, and then total (T) cytoplasmic (C) and nuclear (N) extracts prepared as described in Section 2, were subjected to SDS-PAGE/Western blot analysis
employing a speciﬁc anti-Dp71d antibody. Membranes were stripped and reprobed for actin as loading control (left panel). Densitometric analysis of immunoblot autoradiograms was
performed to determine both the total level and the nuclear/cytoplasmic ratio (n/c) of Dp71d in control and TPEN-treated cells (right panel), relative to untreated cells. Results represent
the mean +/− SEM for 3 separate experiments, with signiﬁcant differences between control and TPEN-treated cells denoted by the p values.
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dsRed-tagged RanQ69L, confocal microscopic analysis showing that
TetraGFP-ZZ shifted from the nucleus to the cytoplasm in the presence
of dsRed-RanQ69L (Fig. 4C), with quantitative analysis conﬁrming this
observation (right panel). Ran is thus clearly implicated as playing a
role in the nuclear import of Dp71d.
3.3. Nuclear import of Dp71d is dependent on IMPα/β1
To conﬁrm the nuclear import ability of the ZZ of Dp71d, we ﬁrstly
used an in vitro reconstituted nuclear transport system based on me-
chanically perforated HTC cells as previously [44,47,59]. Fluorescently
labelled bacterially expressed His-tagged ZZ (DTAF-ZZ) was able to
accumulate rapidly and strongly in the nucleus (Fn/cmax ≈ 7, t1/2≈ 4.5 min, Fig. 5AB, and data not shown), to an extent greater than a
well-characterised Simian Virus SV40 large tumour antigen (T-ag)
NLS-containing GFP fusion protein (Fn/cmax ≈ 2; data not shown),
supporting the idea that ZZ accumulates efﬁciently in the nucleus. To
examine the nuclear import mechanism of Dp71d in more detail, we
added antibodies speciﬁc for different IMPs in the nuclear transport
assay as previously [40,41,55,56]; antibodies to both IMPα2 and
IMPβ1, but not IMPβ3 signiﬁcantly (p b 0.015) reduced (c. 50%) nuclear
accumulation of DTAF-ZZ (Fig. 5AB; see Fig. 5C for pooled data), imply-
ing that Dp71d nuclear import is strongly dependent on IMPα2/β1 and
not other IMPs. To assess the extent to which nuclear accumulation of
Dp71d is dependent on nuclear retention through binding to nuclear
components in addition to active, IMP-dependent transport, ex-
periments were performed in the presence of the nuclear envelope
Fig. 3. Identiﬁcation of key Zn2+-chelating residues conferring Dp71d nuclear translocation. C2C12 cells cultured on coverslips were transiently transfected to express TetraGFP-ZZ (WT)
ormutant derivatives thereof (ZZ-1 to ZZ-5). Cellswereﬁxed, stainedwith DAPI, and then subjected to CLSManalysis; typical single Z-sections are shown (scale bar is 10 μm). A schematic
representation of the zinc ﬁngermotifs (Zn-1 and Zn-2) of the ZZ domain of Dp71d is shown (see also [53]), highlighting the amino acid substitutions analysed; potential Zn2+-chelating
amino acids are shown in bold and mutated residues denoted in red. Quantitative analysis of the levels of nuclear accumulation (Fn/c ratio) of each ZZ derivative mutant was performed
and comparedwith that ofWT, as per the legend to Fig. 1. Results represent themean+/− SEM for three separate experiments (n=50),with signiﬁcant differences betweenmutant and
WT constructs denoted by the p values.
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the level of DTAF-ZZ accumulation fell markedly (Fn/cmax of c. 2.5), in
essentially comparable fashion to the effect on T-ag (Fn/cmax ≈ 1),
which is unable to bind to nuclear components. That nuclear accumula-
tion of DTAF-ZZwas not completely abolished in the presence of CHAPS,
however, indicates that it retains an ability to bind to nuclear compo-
nents, presumably through its Zn2+-ﬁnger domain, but facilitated,
IMP-dependent nuclear import is clearly mainly responsible for its
nuclear accumulation.
To conﬁrm that full length Dp71d can interact with IMPs in a physi-
ological context, pull-down assays were initially performed (Fig. 6A),
whereby recombinant, bacterially expressed GST and GST-Dp71dproteins were immobilised on sepharose, prior to incubation with ly-
sates from C2C12s and subsequent Western blot analysis. Both IMPα2
and β1 were found to bind efﬁciently to GST-Dp71d but not to GST
alone, implying the speciﬁcity of the interaction with IMPα2/β1. Thus,
full length Dp71d can interact with IMPα2/β1. Consistent with this
idea, immunoprecipitation from intact cells indicated that IMPα2 and
IMPβ1 but not IMPβ2, interacted with the ZZ domain expressed as a
TetraGFP-fusion in transfected cells, but not with TetraGFP alone, illus-
trating the speciﬁcity of the interaction between the ZZ domain of
Dp71d and IMPα2/β1 (Fig. 6B). Importantly, IMPα2 and β1 binding
was abolished in the ZZ-4 mutant, which is also impaired in nuclear
localisation, but not in the nonaffected mutant ZZ-1 (see Fig. 3), which
Fig. 4. Dp71d nuclear accumulation occurs through the NPC and is dependent on Ran. (A) C2C12 cells seeded on glass coverslips were treated for 24 h with the Agaricus bisporus lectin
(ABL) diluted in PBS or with PBS alone (Control), prior to ﬁxation, immunostaining using anti-Dp71d primary and ﬂuorescein-coupled secondary (green) antibodies and counterstained
with DAPI (nuclei, blue). (B) C2C12 cells cultured on coverslips were transiently transfected with vector expressing TetraGFP-ZZ fusion protein (green) and 8 h post-transfection were
treated with ABL as described above, and subsequently ﬁxed and stained with DAPI (nuclei, blue). (C) C2C12 cells seeded on glass coverslips were cotransfected to express TetraGFP
fused to the ZZ domain of Dp71d (green) with or without (−) the dominant negative Ran derivative dsRed-RanQ69L (red). Cells were ﬁxed 24 h post-transfection and stained with
DAPI (nuclei, blue). Samples from Panels A, B and C were imaged by CLSM and analysed as per the legend to Fig. 1 (scale bars are 10 μm). Results represent the mean +/− SEM for 3
separate experiments (n = 50), with signiﬁcant differences between control and ABL-treated cells (A and B) or RanQ69L-expressing cells (C) denoted by the p values.
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the target for IMPα2/β1 binding, and that IMPα2/β1 is the nuclear
transporter for Dp71d in living cells.
Finally, to conﬁrm that IMP binding to Dp71d was direct, binding of
recombinant, bacterially expressed ZZ fused to His-tagged GFP to IMPs
was tested in an ALPHAScreen binding assay [43,44], with His-tagged
GFP alone as a control. The ZZ was able to be recognised by GST-
IMPα2 and GST-IMPβ1, but not GST alone (Fig. 6C). Signiﬁcantly, the
IMPα2/β1 heterodimer boundwith very high binding afﬁnity (apparent
dissociation coefﬁcient of c. 0.25 nM, compared to an over 10 times
higher value for IMPα2 or β1 alone), implying that, consistent with
the results from Fig. 5A,B, IMPα2/β1 is likely the major nuclear trans-
porter for Dp71d through the high afﬁnity of the direct interaction.
3.4. Dp71d can shuttle between the nucleus and cytoplasm
Since Dp71d is distributed in both the cytoplasm and the nucleus,
with its subcellular localisation modulated by speciﬁc stimuli [30], it
is likely that Dp71d may be a nucleocytoplasmic shuttling protein,
with a functional nuclear export pathway in addition to its IMPα2/β1-
dependent nuclear import pathway clearly implicated above. To assess
whether Dp71d possesses an exportin-1/CRM1-recognised nuclear ex-
port pathway, the effect on the subcellular distribution of endogenous
and ectopically expressed Dp71d of the CRM1-speciﬁc inhibitor
leptomycin B (LMB) was tested (Fig. 7A–D). Effectiveness of LMB treat-
ment was conﬁrmed using theNES-containing fusion protein constructs
Rev-NES-GFP and its NES mutated variant Rev-NESmut-GFP, as positive
and negative control respectively. As expected, localization of Rev-NES-GFP shifted from the cytoplasm to the nucleus in C2C12 cells upon LMB
treatment, while Rev-NESmut-GFP did not respond to LMB and still
localised to the cytoplasm, conﬁrming that CRM1-mediated nuclear
export was effectively blocked (see Supp. Fig. S3AB). We observed in-
creased nuclear localization of endogenous Dp71d upon LMB treatment,
whichwas supported by quantitative analysis (Fig. 7A). Similarly, ectop-
ically expressed GFP-Dp71d accumulated in the nucleus to a signiﬁcant-
ly (p b 0.0001) greater extent in LMB-treated cells than in control cells
(Fn/c of 2.8 and 0.6 respectively; Fig. 7B right). These results indicate
that Dp71d indeed possess a CRM1-dependent NES. CRM1-recognised
NESs generally include 4 or more closely spaced hydrophobic residues,
often leucines; we identiﬁed ﬁve potential NES-like sequences within
Dp71d, four within the N-terminal half and one in the C-terminal por-
tion (see schematics in Fig. 7C,D, where the putative NES sequences
are shown in the context of the constructs encoding the N- and C-
terminal halves of Dp71d). In an initial attempt to determine the
functionality of these NESs, we tested the effect of LMB on the subcellu-
lar distribution of TetraGFP-Amino and TetraGFP-ZZCarboxyl proteins in
C2C12 cells. We found that TetraGFP-ZZCarboxyl (Fig. 7D), but not
TetraGFP-Amino (Fig. 7C) clearly relocalised from the cytoplasm to the
nucleus upon LMB treatment, resulting in over 4-fold higher levels of nu-
clear accumulation (Fn/c of c. 2 compared to 0.4 in the absence of LMB;
Fig. 7D right), implying that the C-terminus of Dp71d contains a func-
tional CRM1-recognised NES, likely to comprise amino acids 505–515.
To conﬁrm that Dp71d can associate with CRM1 in intact cells, we
performed immunoprecipitation assays using a GFP-Trap approach.
Consistent with the IF data, TetraGFP fused to full-length Dp71d
or TetraGFP-ZZCarboxyl but not TetraGFP alone or TetraGFP-Amino
Fig. 5. Reconstitution of Dp71d nuclear accumulation in vitro; dependence on IMPα2 and IMPβ1. Nuclear import of DTAF-labelled ZZ domain of Dp71d was reconstituted in vitro in
mechanically perforated HTC cells in the presence of exogenous cytosol (45 mg/ml rabbit reticulocyte lysate) and an ATP regeneration system as described in Materials and methods.
(A) CLSM images were acquired periodically for accumulation of DTAF-ZZ (upper panels) into intact nuclei in the absence (No add.) or presence (45 μg/ml) of speciﬁc monoclonal
antibodies to IMPα2, β1 or β3 (BD Biosciences, Franklin Lakes, New Jersey, USA) as indicated, which were pre-incubated with reticulocyte lysate for 15 min at room temperature prior
to addition to the sample well. Nuclear integrity was monitored by exclusion of a Texas Red-labelled 70 kDa dextran (lower panels). (B) Image analysis performed on CLSM images
such as those in (A) using ImageJ (NIH) software to determine the nuclear to cytoplasmic ﬂuorescence ratio (Fn/c), calculated using the equation Fn/c = (Fn− Fb) / (Fc− Fb), where
Fn, Fb and Fc represent the nuclear, background and cytoplasmic ﬂuorescence values respectively. Nuclear import kinetics were plotted using GraphPad Prism and exponential curves
ﬁtted. Each point represents the mean ± SEM, n N 10. (C) The % maximal accumulation (relative to No add.) was calculated from curves such as those in (B). Results represent
mean ± SEM, n = 3. (D) CLSM images were acquired periodically for accumulation of DTAF–ZZ (left panels) and the control protein GFP-T-ag (right panels) into intact nuclei as
per (A), in the absence (upper panels) or presence (lower panels) of 0.025% CHAPS to permeabilise the nuclear membrane, indicated by the lack of exclusion of a 70 kDa dextran
(lower panels in each block). (E) Image analysis performed as per (B) on CLSM images such as those in (D). Each point represents the mean± SEM, n N 10. Note that since steady
state is reached within minutes in the absence of an intact nuclear membrane, data for CHAPS-treated samples are only presented for the ﬁrst 10 min.
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(Fig. 7E). To characterize the NES within Dp71d amino acids 505–515,
we used site-directed mutagenesis to introduce alanine-substitutions
of leucines 509, 512, and 515 in the context of full-length Dp71d se-
quence, and assessed the effect on subcellular localisation. Strikingly, in
strong contrast to the predominantly cytoplasmic localisation of GFP-Dp71d, the NES mutant variant displayed signiﬁcantly (p b 0.0001)
greater nuclear accumulation, with an Fn/c N 1 (Fig. 7F). The clear impli-
cation was that Dp71d retains a CRM1 recognised NES within amino
acids 505–515 that, together with an NLS in the ZZ-domain, confers
the ability to shuttle in signal-dependent fashion between the nucleus
and cytoplasm.
Fig. 6.Dp71d interacts with IMPα2/IMPβ1. (A) Pull down assays were performed by incubating glutathione-sepharose beads preincubatedwith bacterially expressed GST (negative con-
trol) or GST-Dp71d (full length) with nuclear extracts from C2C12 cells. Beads were recovered by centrifugation and eluted proteins were analysed by Western blot using speciﬁc anti-
bodies against IMPα2 and IMPβ1 (upper panel). Inputs correspond to 5% of nuclear extract prior to pull down. Lower panel shows puriﬁed GST and GST-Dp71d proteins that were
visualized by SDS-PAGE followed by Coomassie brilliant blue staining. (B) Complexation of the ZZ domain with IMPs in living cells. C2C12 cells transiently expressing TetraGFP or
TetraGFP-ZZ proteins were immunoprecipitated using GFP-trap and immunoprecipitated proteins subjected to Western blot analysis using the indicated anti-IMP antibodies. Inputs
correspond to 5% of nuclear extract prior to immunoprecipitation. Un, unbound fraction; B, bound fraction. (C) ALPHAScreen binding assays [43] were performed by incubating
the His-tagged ZZ domain of Dp71d with increasing concentrations (0–30 nM) of bacterially expressed GST alone or GST-IMPβ1, -IMPα2, or predimerized GST-IMPα2/β1 (where GST-
IMPβ1 was biotinylated and GST-IMPα2 unlabelled) — see Section 2. Triplicate data points from a single typical experiment are representative of three independent experiments ﬁtted
using SigmaPlot software to determine the apparent dissociation constants (Kd). ND, not able to be determined due to low binding.
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and dynein
Since Dp71d is cytoskeleton-associated, we examined whether the
cytoskeleton plays a role in Dp71d nuclear translocation in comparable
fashion to a number of other proteins of interest [60,61]. C2C12 cells
were treated with the actin-depolymerizing agent cytochalasin B or
the microtubule-depolymerizing agent nocodazole, ﬁxed, stained with
phalloidin or anti-α-tubulin antibody respectively (Fig. 8A), as well as
with a speciﬁc antibody to Dp71d (Fig. 8B). No signiﬁcant changes
were observed in the subcellular distribution of Dp71d after cytochala-
sin B treatment, suggesting that actin ﬁlaments do not play a substantial
role in Dp71d nuclear localisation (Fig. 8B; top panels, with Fn/c valuesof around 1 in both control and treated cells, right). In stark contrast,
nocodazole treatment signiﬁcantly (p b 0.0001) decreased the extent
of nuclear accumulation of endogenous Dp71d (Fn/c of 0.6), compared
with control cells (Fig. 8B bottom panels). Subcellular fractionation/
Western analysis conﬁrmed this (Fig. 8C), with quantitative analysis
indicating that nuclear levels of Dp71d but not its total levels were
signiﬁcantly (p b 0.0001) decreased (~45%) compared to control cells
(Fig. 8C, right), consistent with the idea that efﬁcient Dp71d nuclear
accumulation is dependent on microtubule integrity.
To test the role of themicrotubulemotor protein dynein, involved in
retrograde transport towards the nucleus of a number of proteins
[62,64], in Dp71d nuclear translocation, C2C12 cells were treated with
erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA), an inhibitor of dynein
Fig. 7. Identiﬁcation of a CRM1-recognised nuclear export signal (NES) in the carboxy-terminal domain of Dp71d. (A) C2C12 cells seeded on glass coverslips were incubated for 24 hwith
the CRM1-speciﬁc inhibitor Leptomycin B (LMB) diluted in methanol or with methanol alone (control). Cells were immunostained with primary anti-Dp71d antibody and a ﬂuorescein-
conjugated secondary antibody (green) and counterstained with DAPI (nuclei, blue). (B–D) C2C12 cells seeded on glass coverslips were transfected to express GFP-Dp71d, TetraGFP-
Amino or TetraGFP-ZZCarboxyl (green) and 8 h post-transfection incubated for additional 12 h without (control) or with LMB. Schematics of the N- and C-terminal portions of Dp71d
expressed in the TetraGFP-Amino and TetraGFP-ZZCarboxyl constructs respectively. The putative CRM1-recognised NES sequences located in each portion of Dp71d are shown. Cells
were ﬁxed, counterstained with DAPI (nuclei, blue), imaged by CLSM, and images such as those shown were analysed as per the legend to Fig. 1 for endogenous Dp71d (A) and GFP-
based fusion proteins (B–D), as described in Section 2. Results represent the mean +/− SEM (n = 50), with signiﬁcant differences in the absence or presence of LMB denoted by the p
values. (E) Interaction between the C-terminal domain of Dp71d and CRM1 as determined by immunoprecipitation. Lysates from C2C12 cells transiently transfected to express TetraGFP,
TetraGFP-Dp71d, TetraGFP-Amino or TetraGFP-ZZCarboxyl were immunoprecipitated using GFP-Trap and immunoprecipitated proteins subjected to Western analysis with antibodies
against CRM1andGFP. Inputs correspond to 5%of nuclear extract prior to immunoprecipitation;Un, unboundproteins; B, boundproteins. (F) C2C12 cells transiently transfected to express
GFP fused to full-length Dp71d (GFP-Dp71d-NESWT; NES sequence within amino acids 505–515 is shown) or its mutant variant (GFP-Dp71d-NESmut; mutated residues within the NES
are denoted in red) (green)were cultured on glass coverslips, ﬁxed 24h post-transfection, stainedwith DAPI (nuclei, blue) and subjected to CLSM analysis; typical single optical Z-sections
are shown (scale bar, 10 μm). Fn/c values were determined as above, with signiﬁcant differences between cells expressing WT or Mut NES denoted by the p values.
995R. Suárez-Sánchez et al. / Biochimica et Biophysica Acta 1843 (2014) 985–1001activity. In parallel, cells were treatedwith aurintricarboxylic acid (AA) an
inhibitor of the anterogrademicrotubule motor kinesin, and the effect on
subcellular distribution of Dp71d analysed by immunoﬂuorescence/CLSM. In contrast to cells treated with AA (Fig. 9A), those treated
with EHNA displayed reduced nuclear staining (Fig. 9B), with quanti-
tative analysis indicating a signiﬁcant (p b 0.0001) 30% reduction in
Fig. 8.Disruption ofmicrotubule network impairs Dp71d nuclear localisation. C2C12 cells seeded in glass coverslipswere treated for 4 hwith cytochalasin B (Cyt B) or 5 hwith nocodazole
(Noc), diluted in DMSO, or with DMSO alone (control). (A) Cells were ﬁxed and stained with phalloidin or with an anti-tubulin antibody in order to visualize effects on the actin-based
cytoskeleton and microtubule network, respectively. (B) Cells treated as per (A) were immunolabelled with anti-Dp71d antibody and ﬂuorescein-conjugated secondary antibody
(green) and counterstainingwith DAPI (nuclei, blue). Sampleswere imaged by CLSM (single optical Z-sections are shown; scale bar 10 μm), and image analysed as described in the legend
to Fig. 1. Results represent the mean +/− SEM for 3 separate experiments (n = 50), with signiﬁcant differences between control and Noc-treated cells determined by Student t-test.
(C) Total (T), cytoplasmic (C) and nuclear (N) extracts obtained from control and Noc-treated cells were separated by SDS-PAGE and subjected to Western blot analysis for Dp71d.
Membranes were stripped and reproved with anti-actin antibody to normalize for loading (left panel). Densitometric analysis of the immunoblots was performed as per the legend to
Fig. 2C to determine both the total levels and the nuclear/cytoplasmic ratio (n/c) of Dp71d in control and nocodazole-treated cells (right panel). Results represent the mean +/− SD
for 3 separate experiments, with signiﬁcant differences between control and Noc-treated cells denoted by the p values.
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fects were speciﬁc was implied by the fact that none of the treatments
altered subcellular distribution of β-dystroglycan (Supp. Fig. S4), a
control cytoskeleton-associated protein whose nuclear translocation
is mediated by IMPs. Thus, Dp71d nuclear import appears to be
dependent on dynein, which is presumably the basis of the require-
ment for microtubule integrity for optimal nuclear accumulation
efﬁciency; kinesin does not appear to be involved in Dp71d nuclear
localization.3.6. Physiological role of nuclear Dp71d; interaction with the nuclear enve-
lope protein emerin
Dp71d associates with lamin B1 in PC12 cells to modulate its cell
cycle-associated functions [23]. To investigate additional roles of nucle-
ar Dp71d, we examined the potential interaction of Dp71d with the nu-
clear envelope protein emerin [65], which has recently been found to be
functionally related to β-dystroglycan, a dystrophin-associated protein
[66]. Nuclear extracts from PC12 cells were immunoprecipitated with
Fig. 9.Dynein-dependent transport facilitates nuclear import of Dp71d. C2C12 cells seeded on glass coverslipswere treatedwith the kinesin inhibitor AA (A) or the dynein inhibitor EHNA
(B), diluted in DMSO or H2O, or with DMSO or H2O alone (control). Cells were ﬁxed 12 h later, immunostained for Dp71d (green) and counterstained with DAPI (nuclei, blue). Cell
preparations were analysed by CLSM and single optical Z-sections are shown. Image analysis was performed as described in the legend to Fig. 1. Results represent the mean +/− SEM
(n= 50), with signiﬁcant differences between control and EHNA-treated cells denoted by the p values.
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ies directed against emerin or Dp71d itself. Emerin was coimmuno-
precipitated with the anti-Dp71d antibody (Fig. 10A), whereas neither
protein was recovered after immunoprecipitation using a control anti-
body (IgG0). Analogously, an anti-emerin antibody was consistently
able to coimmunoprecipitate Dp71d. To conﬁrm these results, in vitro
GST pull down assays were performed using Dp71d expressed as GST
fusion in Escherichia coli and subsequently puriﬁed on glutathione-
Sepharose, and emerin produced and labelled in vitrowith [35S]methio-
nine by a coupled transcription-translation rabbit reticulocyte lysate
system. GST-Dp71d immobilised on glutathione-Sepharose beads as
per Fig. 6Awas incubatedwith 35S-labelled emerin and interacting com-
plexes were pulled down and analysed by phosphorimaging. As shown
in Fig. 10B (top panel), a signiﬁcant fraction of 35S-emerin was recov-
ered in the precipitate of GST-Dp71d but not in that of GST alone,
conﬁrming speciﬁc interaction between Dp71d and emerin. To begin
to determine the physiological role of Dp71d-emerin interaction, we
assessed the effect of Dp71d knockdown on emerin distribution. Lysates
from PC12 control (cells stably transfected with an empty vector) and
AS1-Dp71 cells (stably transfected with antisense-Dp71 vector) [23]
were analysed by Western to evaluate Dp71d levels, with GAPDH as a
loading control. Fig. 10C shows a substantial depletion of Dp71 levels
in AS1-Dp71 cells, compared with control cells. Interestingly, in parallel
with decreased immunostaining for Dp71d in AS1-Dp71 cells, a signiﬁ-
cant number of the cells (c. 50% compared to only about 20% in the
absence of knockdown) showed irregular immunolabelling patterns
for emerin, characterised by invaginations of the nuclear envelope, as
compared with control cells (Fig. 10D,E), indicating altered nuclearmorphology as a result of the reduced levels of Dp71d. The clear impli-
cation is that nuclear Dp71d contributes to emerin nuclear envelope
localization and nuclear integrity.4. Discussion
We delineate here for the ﬁrst time the signal sequences and trans-
porters responsible for the nuclear localisation of dystrophin Dp71d,
using the C2C12 cell system as a model. Using various truncation and
point mutant derivatives, we show that the ZZ domain, comprising
two zinc ﬁnger motifs and surrounding amino acid residues, mediates
nuclear import of Dp71d. Additionally, an in vitro reconstituted nuclear
transport assay demonstrates that ZZ-mediated nuclear import of
Dp71d is crucially dependent on IMPα2 and β1, consistent with its abil-
ity to bind directly with high, nM afﬁnity to the IMPα2/β1 heterodimer.
Importantly, complexes of IMPα2/β1withDp71d in intact cells could be
demonstrated in pull down/IP experiments, while Dp71d nuclear im-
port was also sensitive to agents targeting the NPC (ABL), and the dom-
inant negative Ran mutant RanQ69L. All of these results are consistent
with the idea that a conventional, active nuclear import pathway de-
pendent on IMPα2/β1 recognition of ZZ is responsible for Dp71d nucle-
ar localization in intact cells. In addition, it seems clear that binding in
the nucleus, potentially mediated by the ZZ based on the results in the
presence of CHAPS in our in vitro reconstituted nuclear transport system
(Fig. 5D,E), may also contribute to Dp71d's nuclear accumulation, as
has been noted for several other Zn2+-ﬁnger-containing proteins (see
below).
Fig. 10. Dp71d interacts with emerin and Dp71d knockdown alters emerin localization. (A) Nuclear extracts from PC12 control cells were immunoprecipitated with anti-Dp71d or anti-
emerin antibodies or with a control antibody (IgG0). Immunoprecipitated proteins were analysed byWestern analysis using anti-emerin or -Dp71d antibodies. (B) GST and GST-Dp71d
proteins were expressed in Escherichia coli, puriﬁed using glutathione-Sepharose beads, and visualized by SDS-PAGE followed by Coomassie blue staining (bottom panel). GST and GST-
Dp71d proteins immobilised on glutathione-Sepharose beads were incubated with in vitro translated 35S emerin to perform afﬁnity pull-down assays. Phosphorimaging results
documenting 35S emerin association with GST-Dp71d but not GST alone are shown at the top. The input lane represents 10% of the reticulocyte reaction used in the binding assay.
(C) Lysates from control (cells bearing an empty vector) and AS1-Dp71 (cells bearing an antisense-Dp71 vector) clones were subjected to SDS-PAGE/Western analysis with anti-
Dp71d and GAPDH (loading control) antibodies. (D) Control and AS1 cells seeded on coverslips were ﬁxed, double stained with anti-Dp71d (green) and -emerin (red) antibodies and
counterstained with DAPI to enable nuclei to be visualized (blue), prior to be analysed by CLSM. Single typical optical Z-sections were selected to show distribution of Dp71d and emerin
and nuclear envelope morphology. Scale bar, 10 μm. (E) The percentage of cells with abnormal staining of the nuclear envelope is shown. Results represent the mean +/− SEM for 3
separate experiments (n= 200 cells), with signiﬁcant differences between control and AS1-Dp71 cells denoted by the p value.
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that localise in the nucleus, although the speciﬁc role of the Zn2+-
ﬁnger domains in this context has not always been evident. The NLS
of the Zn2+-ﬁnger protein Wt1 (Wilm's tumour 1 protein) has been
localised to the ﬁrst (of four) Zn2+-ﬁngers in the protein, and the sec-
ond of two Zn2+-ﬁngers from TR2 (human testicular receptor 2) is suf-
ﬁcient for nuclear localisation [48,67]. In contrast, the nuclear localising
activity of a number of other proteins cannot be ascribed to particular
Zn2+-ﬁngers within the respective proteins [49,50,68,69], although
mutations that disrupt Zn2+-ﬁnger tertiary structure abrogate nuclear
localisation of NGFI-A and JAZ [68,69], nuclear import in the case of
EKLF/KLF1 appears to be independent of Zn2+-ﬁnger structure [50]. In
the case of Dp71d, it seems clear that Zn2+-ﬁnger structure is essential
for the ZZ-dependent nuclear import, since treatment with the Zn2+-
chelator TPEN signiﬁcantly impairs nuclear localisation and site-
directed mutagenesis and IPs indicate that the third cysteine in the
ﬁrst Zn2+-ﬁnger and second cysteine and histidine residue in the sec-
ondZn2+-ﬁnger are crucial for IMPα2/β1-mediated nuclear localisation
of Dp71d. Based on the results in Fig. 3, however (see Section 3), and the
work of others [48,50,55], it is clear that the Dp71d NLS is complex, and
almost certainly dependent on other residues within the Zn2+-ﬁngerdomain in addition to the Zn2+-ﬁngers themselves. More detailed anal-
ysis is required in the future to establish this formally, and in particular
the interdependence of particular residues within the Zn2+-ﬁnger
domain, its structural conformation, and IMP recognition.
Although critically dependent on interactions with IMPs, nuclear
protein import has also been shown in several cases to be strongly inﬂu-
enced by interactionswith cytoskeletal elements [70], with a direct role
of the microtubule (MT) network observed in facilitating the nuclear
import of speciﬁc cancer regulatory proteins, including p53, PTHrP
and RB [60,61]. Here we show that the MT-depolymerizing agent
nocodazole and the dynein inhibitor EHNA both block nuclear translo-
cation of Dp71d, implying roles for both MT integrity and dynein in
Dp71d nuclear transport. Fig. 11 represents a schematic model for
Dp71d nuclear translocation, dependent on both MTs/dynein and
IMPs. Cytoplasmic Dp71d is normally associatedwith the plasmamem-
brane within the DAPC; we propose that in response to speciﬁc signals
such as phosphorylation (see [71,73]), Dp71d may be released from
the plasma membrane to be transported through the cytoplasm to-
wards the nucleus through theMTmotor protein dynein; subsequently,
in the vicinity of the nucleus, the NLS of Dp71d is recognised by IMPα2/
β1 to enable passage through the NPC (Fig. 11).
Fig. 11. Proposed model for nucleocytoplasmic shuttling mechanism of Dp71d. Dp71d localises in the cytoplasm within the plasma membrane-localised dystrophin-associated protein
complex (DAPC) (1). In response to speciﬁc cellular signals such as phosphorylation, Dp71d disassembles from DAPC to be transported retrogradely towards the nucleus via association
with themotor protein dynein andmicrotubules (2). In analogous fashion to other systems [48,67], the IMPα2/β1 heterodimer recognizes theNLSwithin the ZZ domainofDp71d near the
nuclear periphery, dissociating the protein from dynein and subsequentlymediating its nuclear entry via the NPC (3). After RanGTP-mediated release of Dp71d from the import complex,
this protein assembles a nuclear DAPC,which is anchored to thenuclear envelope through interaction betweenDp71d and both emerin (this study) and lamin B1 (4). A portion ofDp71d is
subsequently exported from the nucleus to the cytoplasm via binding of CRM1/RanGTP to Dp71d's NES (5).
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types [24,26,30], including those analysed here, its presence in the cyto-
plasm is critical to the integrity of DAPCs at the plasma membrane
[74,78]. The results here implicate Dp71d for the ﬁrst time as a
nucleocytoplasmic shuttling protein, whose cytoplasmic localisation
may relate strongly to a CRM1 recognised NES located in the C-
terminal domain (amino acids 505–515). Thus, the balance between
nuclear import and export pathways is likely to be critical to mainte-
nance of the DAPCs at the plasma membrane, as well as yet undeﬁned
nuclear roles of Dp71d.
Dp71d has been found in the nuclear envelope fractions of C2C12
cells [25], and nuclear matrix of HeLa [24] and PC12 cells [79], implying
that Dp71d may play a structural role in the nuclear compartment
analogous to that at the plasma membrane. Consistent with this idea,
Dp71d has been shown to interact in the nucleus with DAPs such as
sarcoglycans, β-dystroglycan, syntrophins, and dystrobrevins, to assem-
ble a nuclear DAPC in various cell types [24,25,27]; Dp71d levels appear
to impact on the levels of DAPs in the nucleus [27], underlining an im-
portant role for nuclear Dp71d, and efﬁcient nuclear import thereof.
Wepreviously showed that Dp71d is a component of themitotic spindleand cytokinesis multiprotein apparati that modulate PC12 cell division
by binding to lamin B1, a nuclear envelope protein involved in cell divi-
sion, with Dp71 knockdown resulting in decreased levels of lamin B1
[23]. Herewe show for the ﬁrst time that Dp71d also binds to the nucle-
ar envelope protein, emerin, both in vivo and in vitro. Signiﬁcantly,
knockdown of Dp71d results in altered subcellular localization of
emerin,with striking impact on nuclearmorphology, further supporting
the idea that nuclear Dp71d, in part through facilitating the localisation
of proteins such as emerin in the nuclear envelope, may be central to a
number of critical nuclear processes including nuclei morphology, gene
expression, and DNA repair.
In summary, this study identiﬁes functional nuclear targeting se-
quences within Dp71d for the ﬁrst time, as well as the transporters
that recognize them, and establishes a dependence on microtubule in-
tegrity for optimal nuclear accumulation. These previously unrecognised
nuclear transport properties are likely to be critical to Dp71d's unique
physiological roles in both the cytoplasm and the nucleus, and particu-
larly with respect to maintenance of nuclear architecture.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.01.027.
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